Literature DB >> 28737773

The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution.

M Arun1, D Brauneis2,3, G Doros3, A C Shelton2,3, J M Sloan2,3, K Quillen2,3, F L Ruberg3,4, V Sanchorawala2,3, C Varga2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28737773     DOI： 10.1038/bmt.2017.148

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.

Authors:  Kaniz Fatema; Morie A Gertz; Marion E Barnes; Amy D Eisinger; Sue Ann C Ness; Bernard J Gersh; Ivana N M Micallef; James B Seward; Stephen S Cha; Kent R Bailey; Teresa S M Tsang
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

2.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

3.  Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.

Authors:  Simone Longhi; Candida Cristina Quarta; Agnese Milandri; Massimiliano Lorenzini; Christian Gagliardi; Lisa Manuzzi; Maria Letizia Bacchi-Reggiani; Ornella Leone; Alessandra Ferlini; Antonio Russo; Ilaria Gallelli; Claudio Rapezzi
Journal:  Amyloid       Date:  2015-06-05       Impact factor: 7.141

4.  Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.

Authors:  S Girnius; D C Seldin; H K Meier-Ewert; J M Sloan; K Quillen; F L Ruberg; J L Berk; G Doros; V Sanchorawala
Journal:  Bone Marrow Transplant       Date:  2013-12-09       Impact factor: 5.483

5.  Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation.

Authors:  Abhishek Singla; William J Hogan; Stephen M Ansell; Francis K Buadi; David Dingli; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; David J Inwards; Patrick B Johnston; Martha Q Lacy; Mark R Litzow; Ivana N Micallef; Luis F Porrata; Shaji K Kumar
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-06       Impact factor: 5.742

6.  Melphalan-induced supraventricular tachycardia: incidence and risk factors.

Authors:  Victor Feliz; Saleem Saiyad; Sumana M Ramarao; Hammad Khan; Fabio Leonelli; Maya Guglin
Journal:  Clin Cardiol       Date:  2011-04-27       Impact factor: 2.882

7.  Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

Authors:  J D Hidalgo; R Krone; M W Rich; K Blum; D Adkins; M-Y Fan; R Brown; S Devine; T Graubert; W Blum; M Tomasson; L T Goodnough; R Vij; J DiPersio; H Khoury
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

8.  Autologous stem cell transplant for multiple myeloma patients 70 years or older.

Authors:  E Muchtar; D Dingli; S Kumar; F K Buadi; A Dispenzieri; S R Hayman; R C Wolf; D A Gastineau; R Chakraborty; W J Hogan; N Leung; P Kapoor; M Q Lacy; S V Rajkumar; M A Gertz
Journal:  Bone Marrow Transplant       Date:  2016-07-04       Impact factor: 5.483

9.  Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.

Authors:  E Peres; J E Levine; Y A Khaled; R B Ibrahim; T M Braun; O I Krijanovski; S Mineishi; M H Abidi
Journal:  Bone Marrow Transplant       Date:  2009-05-25       Impact factor: 5.483
  9 in total
  3 in total

1.  Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation.

Authors:  Graham Lohrmann; Monica Arun Patel; Dina Brauneis; Vaishali Sanchorawala; Shayna Sarosiek; Nirupama Vellanki; Omar K Siddiqi; Frederick L Ruberg; Deepa M Gopal
Journal:  JACC CardioOncol       Date:  2020-12-15

2.  Atrial Involvement in Cardiac Amyloidosis: Beyond Dilatation.

Authors:  Marianna Fontana; Rishi K Patel; Ana Martinez-Naharro
Journal:  JACC CardioOncol       Date:  2020-12-15

3.  Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells.

Authors:  Rui Liu; Dong Li; Fangxu Sun; Antonio Rampoldi; Joshua T Maxwell; Ronghu Wu; Peter Fischbach; Sharon M Castellino; Yuhong Du; Haian Fu; Anant Mandawat; Chunhui Xu
Journal:  Stem Cell Res Ther       Date:  2020-11-05       Impact factor: 6.832
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.